Iron Dextran Injection
Iron Dextran Injection - Related Videos
08:45
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
0 Views •
Cited by 3 •
2022
This article demonstrates how to prepare and administer transferrin-bound nonradioactive isotopic iron for studies of iron transport in mouse pregnancy. The approach for quantifying isotopic iron in fetoplacental compartments is also described.
07:35
Lineage Labeling of Zebrafish Cells with Laser Uncagable Fluorescein Dextran
0 Views •
Cited by 8 •
2011
This protocol delineates a way to label and trace the fate of small groups of cells zebrafish embryos using UV-uncaging of caged fluorescein, followed by whole mount immunolabeling to amplify the signal from the uncaged fluorescein.
02:56
FITC-Dextran Feeding: A Method to Quantify Intestinal Permeability in C. elegans
0 Views •
2023
This video introduces a method of to visualize and measure the integrity of the C. elegans intestine lumen by feeding worms FITC-labeled dextran. The example protocol shows the assay done with 3,3’-diindolylmethane (DIM)-treated and pathogen-fed worms.
12:00
Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
0 Views •
Cited by 9 •
2015
The objective of this protocol is to incorporate SDF-1α, a stem cell homing factor, into dextran sulfate-chitosan nanoparticles. The resultant particles are measured for their size and zeta potential, as well as the content, activity, and in vitro release rate of SDF-1α from the nanoparticles.
03:06
Culturing Mycobacterium tuberculosis Under Iron-Limited Conditions
0 Views •
2025
Source: Gupta, S., et al. Isolation and Characterization of Extracellular Vesicles Produced by Iron-limited Mycobacteria. J. Vis. Exp. (2019)This video demonstrates the procedure for culturing Mycobacterium tuberculosis under iron-limited conditions to induce iron stress and promote the secretion of siderophores that support bacterial survival.
FAQs
After administration, macrophages in the reticuloendothelial system process the iron-dextran complex. They release elemental iron into circulation, where transferrin binds and transports it to sites requiring iron. This pathway makes the administered iron available for incorporation into hemoglobin and other iron-containing proteins, linking macrophage processing with restoration of iron-dependent cellular functions.
Iron availability connects erythropoiesis, immune function, and host-microbe competition. Restoring iron supports production of hemoglobin and other iron-containing proteins, while changes in accessible iron are relevant to how hosts and microbes compete for this resource. Iron Dextran Injection therefore provides a clinical context for examining iron metabolism alongside immune and infection-related processes.
The key distinction is the route and suitability of replacement. Iron Dextran Injection delivers iron parenterally, whereas oral supplementation may be inadequate or unsuitable for some treatment situations. This makes the injectable approach relevant when restoring iron availability cannot rely effectively on oral administration, while its use also requires attention to reactions associated with parenteral delivery.
Administration requires appropriate dosing and clinical monitoring because rapid reactions, including hypersensitivity, can occur. Monitoring is therefore not an incidental step: it supports recognition of potentially serious responses during or after delivery. The need for dose selection and observation distinguishes this treatment from a simple, unsupervised approach to correcting inadequate iron availability.
This treatment may be considered when oral iron supplementation is inadequate or unsuitable and parenteral replacement is needed. In clinical research, it can also serve as a way to examine how restoring iron availability affects erythropoiesis, iron-containing proteins, and the relationship between iron metabolism and immune function. The specific decision remains dependent on appropriate dosing and monitoring.
By increasing available iron after macrophage processing and transferrin binding, the treatment supports restoration of substrates used in hemoglobin and other iron-containing proteins. Studies can consequently relate iron replacement to erythropoiesis and immune context, including host-microbe competition for iron. Interpretation should also account for administration-associated hypersensitivity risk and the need for clinical observation.